368 related articles for article (PubMed ID: 32805515)
1. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
[TBL] [Abstract][Full Text] [Related]
2. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
3. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Tomita Y; Sato R; Ikeda T; Sakagami T
Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
[TBL] [Abstract][Full Text] [Related]
4. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
5. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
6. Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir C; Kucuksezer UC; Tamay ZU
Allergy; 2020 Jul; 75(7):1824-1827. PubMed ID: 32330314
[No Abstract] [Full Text] [Related]
7. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
Front Immunol; 2020; 11():970. PubMed ID: 32574258
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
[TBL] [Abstract][Full Text] [Related]
9. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Hachim A; Kavian N; Cohen CA; Chin AWH; Chu DKW; Mok CKP; Tsang OTY; Yeung YC; Perera RAPM; Poon LLM; Peiris JSM; Valkenburg SA
Nat Immunol; 2020 Oct; 21(10):1293-1301. PubMed ID: 32807944
[TBL] [Abstract][Full Text] [Related]
10. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
Gruer L; Bhopal R
BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
[No Abstract] [Full Text] [Related]
11. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
O'Connor E; Teh J; Kamat AM; Lawrentschuk N
Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
[No Abstract] [Full Text] [Related]
12. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.
Fierz W; Walz B
Front Immunol; 2020; 11():1120. PubMed ID: 32582200
[TBL] [Abstract][Full Text] [Related]
13. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
14. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
Bryant JE; Azman AS; Ferrari MJ; Arnold BF; Boni MF; Boum Y; Hayford K; Luquero FJ; Mina MJ; Rodriguez-Barraquer I; Wu JT; Wade D; Vernet G; Leung DT
Sci Immunol; 2020 May; 5(47):. PubMed ID: 32430309
[TBL] [Abstract][Full Text] [Related]
15. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
16. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
[TBL] [Abstract][Full Text] [Related]
17. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
[TBL] [Abstract][Full Text] [Related]
18. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
Front Immunol; 2020; 11():2059. PubMed ID: 33013871
[TBL] [Abstract][Full Text] [Related]
19. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
20. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
